Harmful ingredients

Pregnancy-Safe Skincare: Complete Ingredient List to Avoid (Dermatologist Guide)

Dr Surbhi, MD (Dermatology)

Dermatologist, founder of Dermatocare · Last updated

✓ Reviewed by a dermatologist

Pregnancy is not the time to experiment with unverified skincare trends. It is a time to minimize avoidable chemical exposure, particularly to ingredients that are hormonally active, systemically absorbable, penetration-enhancing, or poorly evaluated for fetal exposure.

At Dermatocare, we follow a precautionary, evidence-aligned screening methodology based on our proprietary database standards. Every evaluated ingredient is classified into one of three tiers: Avoid in Pregnancy, Use with Caution, or Unflagged Base

Why Ingredient Choice Matters More in Pregnancy

·       Foetal organs (brain, thyroid, reproductive system) are highly hormone-sensitive.

·       Multiple daily products lead to cumulative exposure.

·       Many "clean" or "paraben-free" products still contain hidden risk ingredients.

If a safer alternative exists, there is no medical justification to accept uncertainty.

Ingredients to Avoid in Pregnancy

Retinoids & Vitamin A derivatives

Ingredients: Ingredients: Retinol, Retinal / Retinaldehyde, Retinyl Palmitate, Retinyl Acetate, Retinyl Propionate, Retinyl Linoleate, Retinyl Ascorbate, Retinyl Retinoate, Hydrogenated Retinol, Hydroxypinacolone Retinoate, Ethyl Lactyl Retinoate, Glyceryl Diretinoate, Methoxy PEG-12 Retinamide, Retinoxytrimethylsilane, Tocopheryl Retinoate, Triacetyl Retinoyl Phytosphingosine, Adapalene, Tretinoin, Tazarotene, Oral Isotretinoin.

Toxicological Rationale: Systemic retinoids bind Retinoic Acid Receptors (RAR) to disrupt homeobox gene transcription during early organogenesis, inducing classic retinoid embryopathy (craniofacial, central nervous system, and cardiovascular malformations). Topical derivatives absorb or enzymatically convert into active retinoic acid in the skin; because no safe lower threshold exists for fetal exposure, all topical forms are strictly contraindicated.

Skin-lightening & pigment-altering agents

Ingredients: Hydroquinone, Monobenzone (Monobenzyl ether of hydroquinone), Mequinol, Alpha-Arbutin, Beta-Arbutin, Deoxyarbutin, Bearberry Extract (Uva Ursi), Mercury compounds.

Toxicological Rationale:

  • Hydroquinone is absorbed through skin to an unusually high degree, in the region of 35 to 45 percent of the applied dose in some formulations [4], and while direct human pregnancy data is limited, it has shown fetotoxic effects in some animal studies [5].

  • The arbutin family (alpha-arbutin, beta-arbutin/arbutin, deoxyarbutin) is often marketed as a gentler alternative, but each hydrolyses into free hydroquinone once applied to skin, so the same caution applies.

  • Resorcinol and phenol are systemically absorbed skin-peeling agents with their own toxicity profile at professional-peel concentrations.

  • Mercury compounds are banned in cosmetics in India and most countries but still appear in some imported or unregulated skin-lightening creams; they cross the placental barrier and cause permanent foetal neurotoxicity.

Hormone-altering / anti-androgenic drugs

Note: These are prescription medicines, not cosmetic ingredients, but they are included here because they are sometimes prescribed for hair loss or hormonal acne. They are not rated in our database.

Ingredients: Finasteride, Spironolactone, Cyproterone Acetate, Flutamide.

Toxicological Rationale:

Finasteride inhibits 5-alpha-reductase and is associated with feminisation of a male foetus; even handling crushed tablets is contraindicated for a pregnant woman [6].

Spironolactone blocks androgen receptors and can interfere with normal male genital development during the critical first-trimester window [7].

Both are considered contraindicated in pregnancy by standard prescribing guidance, and reliable contraception is recommended for anyone using them who could become pregnant [8].

Few Old Chemical Filters

Ingredients: Oxybenzone (Benzophenone-3), Benzophenone, Benzophenone-2, Benzophenone-4, Benzophenone-5, Benzophenone-8, Benzophenone-9, Octinoxate, Homosalate, 4-Methylbenzylidene Camphor, 4-Aminobenzoic Acid (PABA), Ethylhexyl Dimethyl PABA.

Rationale: Rationale: In an FDA-sponsored maximal-usage trial, six of these older filters, avobenzone, oxybenzone, octocrylene, homosalate, octisalate and octinoxate, were absorbed into the bloodstream above the regulatory threshold that triggers a safety review, after just a few days of whole-body use [9].

Oxybenzone in particular has been measured in amniotic fluid, cord blood and breast milk, and a systematic review of human and animal studies found evidence of endocrine activity, though it concluded the reproductive risk in humans is not yet fully established and needs more standardised research [10].

Mineral sunscreens (zinc oxide and titanium dioxide, coated nano or non-nano) remain the preferred choice in pregnancy; the newer organic filters that behave very differently from this group are covered in Part 2, not here.

Long-Chain and Branched Parabens

Ingredients: Butylparaben, Isobutylparaben, Isodecylparaben, Isopropylparaben, Propylparaben.

Rationale: Parabens cross the placenta; a study measuring paired maternal and cord blood found methyl-, ethyl- and propylparaben all transferred from mother to foetus, with their hydroxylated metabolites transferring even more readily [11].

Isopropyl- and isobutylparaben are banned outright in EU cosmetics, and butylparaben and propylparaben are restricted to a low permitted concentration, on endocrine-disruption grounds [12]. Methyl- and ethylparaben, which are far more common in ordinary cosmetics and permitted at a higher concentration, are covered in Part 2 rather than here.

Few Formaldehyde-Releasing Preservatives

Ingredients: Methylene Glycol (also labelled Methanediol or Formalin), Quaternium-15, Sodium Hydroxymethylglycinate, 2-Bromo-2-Nitropropane-1,3-Diol (Bronopol), 5-Bromo-5-Nitro-1,3-Dioxane (Bronidox).

Rationale: These compounds release free formaldehyde into the finished product. Formaldehyde is a recognised mutagen, and occupational studies have linked high-level exposure to an increased risk of spontaneous abortion [13]. Methylene Glycol deserves particular attention: it is the ingredient behind most "formaldehyde-free" keratin and hair-smoothing treatments, and it is chemically formaldehyde in its liquid hydrate form, which is why hair-straightening services are one of the few places a pregnant woman can encounter formaldehyde at levels approaching occupational exposure limits, especially in a poorly ventilated salon [14]. Plain formaldehyde and its urea-based releasers (DMDM Hydantoin, Diazolidinyl Urea and others), which are typically present at much lower use levels in leave-on cosmetics, are covered in Part 2.

Phthalates (Often Hidden in "Fragrance")

Ingredients: Diethyl Phthalate (DEP), Dibutyl Phthalate (DBP).

Rationale: Phthalates are anti-androgenic and penetrate skin easily. A landmark human study found that higher prenatal phthalate exposure was associated with a shorter anogenital distance in baby boys, a recognised marker of reduced androgen action in utero, along with other signs of altered genital development [16].

Phthalates are frequently present without being individually listed, hidden inside an undisclosed "Fragrance" or "Parfum" entry, which is why fragrance-free is a genuinely useful filter in pregnancy, not just a marketing term.

Cyclic Silicone

Ingredient: Cyclotetrasiloxane (D4).

Rationale: D4 is listed by the EU chemicals agency as a Substance of Very High Concern on persistence and bioaccumulation grounds, and separately, animal studies have shown reduced fertility, litter size and implantation effects at sufficient exposure [17]. Whether D4 also acts through direct hormone-receptor binding is scientifically debated, with a 2024 reanalysis concluding the estrogenic mechanism specifically is implausible, but the persistence and animal-reproduction findings stand independently of that narrower debate.

D4 is chemically distinct from D5 (Cyclopentasiloxane), which is not similarly restricted and is not treated as a pregnancy concern here — the two are easy to confuse on an ingredient list but are not interchangeable.

Industrial Solvents

Ingredients: Toluene, Trimethylbenzene.

Rationale: These volatile solvents are most often encountered in nail products (polish, remover, hardener) rather than facial skincare. Toluene in particular has documented developmental toxicity at high, occupational-level exposure, with effects resembling foetal alcohol syndrome described in cases of heavy solvent exposure [18]; the risk at the low, intermittent exposure of occasional home nail care is far smaller, but working with these solvents daily, as in a poorly ventilated salon, is the exposure pattern worth actively avoiding or minimising in pregnancy.

Boron Compounds

Ingredients: Boric Acid, Sodium Borate, Potassium Borate, MEA-Borate, MIPA-Borate , Sodium Perborate.

Rationale: Boric acid and sodium borate are classified in the EU as presumed human reproductive toxicants and have been prohibited in EU cosmetics since 2019 on that basis [19].

Pennyroyal

Ingredients: Mentha Pulegium Oil, Mentha Pulegium Extract (Pennyroyal).

Rationale: Pennyroyal is treated more strictly than any other essential oil discussed on this page, and it is the only one in this avoid tier rather than the caution tier below. Its pulegone content is a direct uterine stimulant and a liver toxin, and pennyroyal has a long, documented history of use, and harm, as a folk abortifacient [20]. Every other essential oil discussed on this page, including camphor, clove and the group sometimes called "uterine-stimulating oils," sits one tier lower; pennyroyal does not.

Ingredients to Use With Caution in Pregnancy

Salicylates

Ingredients: Salicylic Acid, Sodium Salicylate, Betaine Salicylate, Capryloyl Salicylic Acid, Trethocanic Acid, Amyl Salicylate, Benzyl Salicylate, Methyl Salicylate (Wintergreen Oil), Salicylaldehyde, Butyloctyl Salicylate, Octisalate.

Rationale: Systemic salicylates inhibit cyclooxygenase (COX) and prostaglandin synthesis. At high, continuous systemic doses—such as oral aspirin or high-concentration professional chemical peels—salicylates pose a risk of premature closure of the fetal ductus arteriosus and neonatal bleeding.

However, low-concentration topical leave-ons (≤2%), face washes, or trace fragrance fixatives (e.g., benzyl salicylate) yield minimal transdermal absorption.

Sunscreen filters like Octisalate and Butyloctyl Salicylate function as UV absorbers rather than exfoliating actives, placing this entire class in the caution tier rather than strict avoidance.

Depigmenting Agents

Ingredients: Psoralea Corylifolia Seed Extract (Babchi extract).

Rationale: Raw Psoralea corylifolia seed extract contains crude psoralens and furocoumarins that carry phototoxic and potential endocrine-disrupting risks. In contrast, highly purified (>99%) isolated bakuchiol does not contain these phototoxic compounds and is not subject to this specific caution.

Synthetic Antioxidants

Ingredients: BHA (Butylated Hydroxyanisole), Tetrabutyl Ethylidenebisphenol.

Rationale: BHA is listed as a Category 1 endocrine-disrupting chemical by the EU, with weak oestrogenic and anti-androgenic activity shown in laboratory studies, and is classified by the US National Toxicology Program as reasonably anticipated to be a human carcinogen [15].

Older Antimicrobials

Ingredients: Triclosan, Triclocarban.

Rationale: Both agents readily cross the skin barrier and enter maternal circulation, where clinical studies have associated them with altered maternal thyroid hormone levels (T3​/T4​), which are critical for fetal neurodevelopment.

Occasional rinse-off exposure (e.g., hand soaps) carries negligible risk compared to daily, widespread leave-on application.

Standard Aromatherapy Essential Oils

Ingredients: Oils derived from Camphor, Cassia/Cinnamon Bark, Clove, Fennel, Juniper, Peppermint/Spearmint, Nutmeg, Basil, Parsley, Rosemary, Tansy, Thyme, and Wormwood.

Rationale: These botanical oils contain concentrated active constituents—such as thujone, camphor, apiole, myristicin, estragole, or cinnamaldehyde—that possess theoretical or documented neurotoxic, emmenagogic, or uterine-stimulating properties at pharmacological doses. Parsley seed oil (high in apiole) carries the strongest evidence of uterine stimulation.

When used in cosmetics at trace fragrance concentrations (≤0.1%), systemic absorption is minimal.

Fragrances

Ingredients: Camphor, Eugenol, Eugenyl Acetate, Isoeugenol, Isoeugenyl Acetate, Anethole, Carvone, Musk Ketone, Hexamethylindanopyran, Parfum / Fragrance.

Rationale: Isolated aromatic compounds carry the exact same biological profile as the essential oils from which they are derived.

Generic terms like "Parfum" or "Fragrance" may contain these undisclosed isolates alongside phthalate solvents (e.g., diethyl phthalate), making fragrance-free options preferred for daily pregnancy care.

PFAS ("Forever Chemicals")

Ingredients: Perfluorodecalin, Perfluorodimethylcyclohexane, Perfluorohexane, Perfluorohexylethyl Triethoxysilane, PTFE (Polytetrafluoroethylene), Ethyl/Methyl Perfluorobutyl Ethers, and related fluorinated polymers.

Rationale: Per- and polyfluoroalkyl substances (PFAS) readily cross the placental barrier, persist in body tissues, and bioaccumulate in fetal organs. Epidemiological data link elevated maternal PFAS levels to an increased risk of preeclampsia, gestational hypertension, and lower birth weight. Any INCI entry containing "perfluoro-", "polyfluoro-", or "PTFE" should be minimized.

Hair Dyes and Oxidation Colorants

Ingredients: P-Phenylenediamine (PPD), Toluene-2,5-Diamine, Resorcinol derivatives (Hexylresorcinol, 4-Butylresorcinol), Basic Green 4, Ethanolamine Thioglycolate.

Rationale: Transdermal absorption through an intact scalp during single, intermittent coloring sessions is extremely low, and clinical trials show no increase in fetal malformations. The slight reproductive risks reported in literature apply almost exclusively to occupational exposure (e.g., salon workers handling dyes daily without adequate ventilation) rather than occasional personal hair coloring.

However, frequent exposure or application on compromised skin increases contact sensitization risks and systemic amine uptake.

Preservatives (Caution Tier)

  • Ingredients: DMDM Hydantoin, Diazolidinyl Urea, Imidazolidinyl Urea, Methylparaben, Ethylparaben, Sodium Methylparaben, Sodium Ethylparaben.

  • Rationale: These ingredients represent low-exposure, highly regulated preservatives. Short-chain parabens (methyl- and ethylparaben) metabolize rapidly into non-toxic p-hydroxybenzoic acid and exhibit negligible estrogenic potency compared to long-chain variants (butyl/propyl/isobutylparaben). Similarly, formaldehyde donors in this tier release trace free formaldehyde well below sensitization or systemic toxicity thresholds.

Modern Chemical and Hybrid UV Filters

  • Ingredients: Avobenzone, Octocrylene,Tinosorb S, Tinosorb M, Tinosorb A2B, Uvinul A Plus, Uvinul T 150, Mexoryl SX/XL, TriAsorB, Octisalate, Polysilicone-15.

  • Rationale: Physical mineral sunscreens (Zinc Oxide and Titanium Dioxide) remain the Primary Gold Standardduring pregnancy because they sit on top of the skin without any systemic absorption. However, Indian dermatological guidelines recommend physical (mineral) sunscreens for daily use during pregnancy.

Modern organic filters (such as Tinosorb, Uvinul, and Mexoryl) permitted across international regulatory frameworks due to high molecular weight, photostability, and minimal transdermal absorption

Uncoated Nano Mineral Sunscreens

  • Ingredients: Titanium Dioxide (Nano, Uncoated), Zinc Oxide (Nano, Uncoated).

  • Rationale: Uncoated mineral nanoparticles can generate reactive oxygen species (ROS) when exposed to UV light due to unpassivated photocatalytic surface activity. Coated nanoparticles (passivated with silica, alumina, or dimethicone) and standard non-nano minerals prevent this oxidative stress and remain the gold standard for pregnancy sun protection.

Disclaimer

Database & Compliance Disclaimer

Evaluations are generated by Dermatocare’s proprietary database engine based on published INCI disclosures at review.

All cosmetics discussed meet standard legal safety regulations

Dermatocare profile matches reflect independent screening criteria that apply stricter precautionary benchmarks than standard guidelines. Algorithmic profile matches do not constitute personalized clinical advice or physician endorsement

About Our Stringent Precautionary Framework

Our Pregnancy-Safe Skincare Standard applies an exceptionally strict, ultra-precautionary screening framework that is significantly more conservative and stringent than standard regulatory guidelines (e.g., FDA, EU SCCS) or routine clinical practice.

Exclusion from our approved list reflects our ultra-conservative ingredient screening threshold, not a finding of toxicity, product defect, or lack of quality.

Formulation Changes & INCI Verification

Brand formulations, ingredient suppliers, and trade name disclosures update frequently. All product evaluations are based strictly on publicly disclosed INCI lists available at the time of review. Despite rigorous auditing, formula reformulations can occur without notice.

We strongly advise users to verify the physical INCI packaging label or official brand website before purchasing or applying any product.

Medical Consultation & Professional Scope

The information provided by Dermatocare is designed to support informed decision-making and educational awareness; it does not constitute individual medical advice, diagnosis, or treatment.

Final product selection during pregnancy should always be made in consultation with your attending obstetrician or dermatologist.

Database Scope:

This ingredient database is non-exhaustive and relies on manufacturer-published INCI disclosures at the time of screening.

Dermatocare assumes no legal liability for undisclosed formulation updates, omitted ingredients, or automated pregnancy compatibility classifications. Database evaluations do not constitute medical advice. Users must always consult a qualified physician or dermatologist prior to using any skincare product during pregnancy.

1.     Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837-841. doi:10.1056/NEJM198510033131401. PMID: 3162101. View on PubMed

2.     Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015;173(5):1132-1141. doi:10.1111/bjd.14053. PMID: 26215715. View on PubMed

3.     Panchaud A, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52(12):1844-1851. doi:10.1177/0091270011429566. PMID: 22174426. View on PubMed

4.     Wester RC, Melendres J, Hui X, et al. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition. J Toxicol Environ Health A. 1998;54(4):301-317. PMID: 9652540.

5.     Cosmetic Ingredient Review. Amended Safety Assessment of Hydroquinone as Used in Cosmetics. View report

6.     Finasteride use during pregnancy and early neonatal outcome: a case report. PMID: 29855987. View on PubMed

7.     Case report: A pregnant woman accidentally treated with spironolactone in mid-gestation. PMC11306061. View on PMC

8.     Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. PMC11172682. View on PMC

9.     Matta MK, Florian J, Zusterzeel R, et al. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA. 2020;323(3):256-267. doi:10.1001/jama.2019.20747. PMID: 31961417. View on PubMed

10.  Ghazipura M, McGowan R, Arslan A, Hossain T. Exposure to benzophenone-3 and reproductive toxicity: A systematic review of human and animal studies. Reprod Toxicol. 2017;73:175-183. doi:10.1016/j.reprotox.2017.08.015.

11.  Song S, He Y, Zhang T, Zhu H, Huang X, Bai X, Zhang B, Kannan K. Profiles of parabens and their metabolites in paired maternal-fetal serum, urine and amniotic fluid and their implications for placental transfer. Ecotoxicol Environ Saf. 2020;191:110235. doi:10.1016/j.ecoenv.2020.110235. PMID: 31986458. View on PubMed

12.  Commission Regulation (EU) No 358/2014 and No 1004/2014 amending Annexes to Regulation (EC) No 1223/2009 on cosmetic products (paraben restrictions).

13.  UK Teratology Information Service. Exposure to Formaldehyde in Pregnancy. View monograph

14.  California Department of Toxic Substances Control. Decision Document for Hair Straightening Products Containing Formaldehyde. View document

15.  Jeong SH, Kim BY, Kang HG, Ku HO, Cho JH. Effects of butylated hydroxyanisole on the development and functions of reproductive system in rats. Toxicology. 2005;208(1):49-62. PMID: 15664432. View on PubMed

16.  Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056-1061. doi:10.1289/ehp.8100. PMID: 16079079. View on PubMed

17.  European Chemicals Agency. Substance Information: Octamethylcyclotetrasiloxane (D4), EC No. 209-136-7. Listed on the Candidate List of Substances of Very High Concern as PBT and vPvB. View ECHA substance record

18.  Reproductive toxicology and teratology of abused toluene. Syst Biol Reprod Med. PMID: 20377315. View on PubMed

19.  Commission Regulation (EU) 2019/831 amending Annex II to Regulation (EC) No 1223/2009 on cosmetic products (boric acid and borate prohibition).

20.  Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996;124(8):726-734. PMID: 8633832.

21.  American College of Obstetricians and Gynecologists. Low-Dose Aspirin Use During Pregnancy. Committee Opinion. View ACOG guidance

22.  Triclosan and thyroid hormone disruption studies, reviewed in: Weatherly LM, Gosse JA. Triclosan exposure, transformation, and human health effects. J Toxicol Environ Health B Crit Rev. 2017;20(8):447-469. PMID: 29182464.

23.  Tisserand R, Young R. Essential Oil Safety: A Guide for Health Care Professionals. 2nd ed. Edinburgh: Churchill Livingstone Elsevier; 2014.

24.  Bommarito PA, Ferguson KK, Meeker JD, McElrath TF, Cantonwine DE. Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk. Environ Health Perspect. 2021;129(10):107004. doi:10.1289/EHP9091. PMID: 34637358. View on PubMed

25.  MotherToBaby. Hair Treatments Fact Sheet. NCBI Bookshelf. View fact sheet

26.  Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of the UV filter Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Bemotrizinol / Tinosorb S), SCCS/1546/15. European Commission. View SCCS opinion

Not sure which one is right for you?

Answer a few questions and get a full AM and PM routine built for your skin — free, and put together by a dermatologist.

Build my free routine →